Afghanistan pharmaceutical sector development: Problems and prospects

Southern Med Review

Volumn 4, Issue 1, 2011, Pages 29-39

  Harper, Jonathan ^a   Strote, Gunnar ^b  

^a Independent International Pharmaceutical Policy and Regulation Consultant   (Hungary)

^b GFA CONSULTING GROUP   (Germany)

Author keywords

Afghanistan; Counterfeit medicines; Medicines policy; Medicines pricing; Medicines regulation; Pharmaceutical situation

Indexed keywords

AFGHANISTAN; ARTICLE; CLINICAL ASSESSMENT TOOL; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MARKETING; FINANCIAL MANAGEMENT; GOVERNMENT REGULATION; HEALTH CARE MANAGEMENT; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; PHARMACY; PUBLIC HEALTH; QUALITY CONTROL; REIMBURSEMENT; STRUCTURED INTERVIEW;

EID: 79955018208     PISSN: None     EISSN: 11742704     Source Type: Journal    
DOI: 10.5655/smr.v4i1.75     Document Type: Article

References (37)

1. Stewart F, Brown G. Fragile States. CRISE Working Paper No. 51 January 2009. Available from URL: http://www.crise.ox.ac.uk/pubs/workingpaper51.pdf [Accessed 2010 Nov 14]
2. Failed States Index. The Fund For Peace. Available from URL: http://www.fundforpeace.org/web/index.php?option=com_content&task=view&id=99&Itemid=140 [Accessed 2010 Nov 14]
3. Corruption Perceptions Index 2010. Transparency International. Available from URL: http://www.transparency.org/policy_research/surveys_indices/cpi/2010/results [Accessed 2010 Nov 10]
4. Human Development Report. UNDP, New York 2010. Available from URL: http://hdr.undp.org/en/media/HDR_2010_EN_Table1_reprint.pdf [Accessed 2011 Feb 17]
5. Indicators [Online]. The World Bank. Available from URL: http://data.worldbank.org/indicator [Accessed 2010 Nov 9]
6. Human and income poverty: developing countries/Population living below national poverty line), Human Development Indices: A statistical update 2008, UNDP, New York 2008. Available from URL: http://hdr.undp.org/en/media/HDI_2008_EN_Tables.pdf [Accessed 2010 Nov 8]
7. WHO Global Health Observatory (GHO) 2010. Available from URL: http://www.who.int/gho/en [Accessed 2010 Nov 10]
8. WHO. The world medicines situation [WHO/EDM/PAR/2004.5]. Geneva: WHO, 2004 [online]. Available from URL: http://www.searo.who.int/LinkFiles/Reports_World_Medicines_Situation.pdf [Accessed 2010 Nov 9]
9. Baghdadi G, Chomilier C, Graaff P. Pharmaceutical Situation in Afghanistan. Preliminary Assessment. WHO, 14-23 January 2002. Available from URL: http://whqlibdoc.who.int/HQ/2002/WHO_EDM_DAP_2002.1.pdf [Accessed 2010 Nov 10]
10. Sabri B, Siddiqi S, Ahmed AM, Kakar FK, Perrot J. Towards sustainable delivery of health services in Afghanistan: options for the future. Bull World Health Organ. 2007 Sep; 85(9):712-8.
11. The Essential Package of Hospital Services for Afghanistan. Islamic Republic of Afghanistan Ministry of Public Health July 2005. Available from URL: http://www.msh.org/afghanistan/pdf/Afghanistan_EPHS.pdf [Accessed 2011 Feb 14]
12. Harper JR, Shahab A. Afghanistan Pharmaceutical Sector EC Identification Mission Report (FWC contract 144147). European Commission; 2008.
13. WHO Operational Package for assessing, monitoring and evaluating country pharmaceutical situations''. Guide for coordinators and data collectors. WHO Geneva 2007. Available from URL: http://apps.who.int/medicinedocs/documents/s14877e/s14877e.pdf [Accessed 2010 Oct 22]
14. Mansoor, B, Najib, Mohd. Baseline Drug Indicator Study, A comparative Cross-Sectional Study in SCA Health Facilities in Afghanistan, Part II Results and Next Steps. Swedish Committee for Afghanistan, 2003.
15. WHO Data Collection Tool for the Review of Drug Regulatory Systems. WHO Geneva, 2007. Available from URL: http://www.who.int/medicines/areas/quality_safety/regulation_legislation/ENdatacollectiontool.pdf
16. How to Develop and Implement a National Drug Policy - WHO Policy Perspectives on Medicines, No. 006, 2003. Available from URL: http://infocooperation.org/hss/en/d/Js4869e/5.html [Accessed 2010 Oct 22]
17. Annex 5 WHO good distribution practices for pharmaceutical products. WHO Technical Report Series 957. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-fourth report. WHO Geneva, 2010. Available from URL: http://whqlibdoc.who.int/trs/WHO_TRS_957_eng.pdf (Accessed Nov 9 2010)
18. Afghanistan Private Pharmacies Survey. Management Sciences for Health (August 2004) Hard copy only, referenced in other reports
19. WHO Medicines Strategy 2004-2007: countries at the core. WHO Geneva, 2004 Available from URL: http://whqlibdoc.who.int/hq/2004/WHO_EDM_2004.5.pdf [Accessed 2010 Nov 10]
20. Good Governance for Medicines. Curbing Corruption in Medicines Regulation and Supply. WHO Geneva, 2007. Available from URL: http://www.who.int/medicines/areas/policy/goodgovernance/GGM.pdf [Accessed 2010 Nov 10]
21. Coordinated Procurement and Distribution System (CPDS) Governance Framework. General Directorate of Pharmaceutical Affairs Ministry of Public Health, Islamic Republic of Afghanistan, March 2010. PDF sent by EC
22. Paterson A, Karimi A. Understanding markets in Afghanistan: A study of the market for pharmaceuticals. Afghanistan Research and Evaluation Unit. Kabul Afghanistan, December 2005. Available from URL: http://www.a-acc.org/files/Understanding%20Markets%20Pharmaceuticals%20CS%5B1%5D.pdf [accessed 2010 Nov 9]
23. Drug Quality Assessment Study Afghanistan 2007. Ministry of Public Health Islamic Republic of Afghanistan. Available from URL: http://www.moph.gov.af/en/reports/Afghanistan-National-Drug-Quality-Assessment-2007-English.pdf [Accessed 2010 Nov 10]
24. Coincidence or Crisis? Prescription Medicine Counterfeiting. Pitts PJ Editor, Stockholm Network London 2006. Available from URL: www.stockholm-network.org/./d41d8cd9-Coincidence%20or%20Crisis.pdf [Accessed 2010 Nov 4]
25. Report of the situation of counterfeit medicines based on data collection tool WHO Regions for Africa and Eastern Mediterranean. WHO Geneva 2010. Available from URL: http://www.who.int/medicines/services/expertcommittees/pharmprep/WHO-ACM-3IMPACTSurveyDataCollectionToolReport.pdf [Accessed 2010 Nov 4]
26. Afghanistan Health and Nutrition Sector Strategy (HNSS) 2008-2013. Ministry of Public Health, Ministry of Agriculture, Irrigation & Livestock Islamic Republic of Afghanistan, 2008. Available from URL: http://www.moph.gov.af/en/downloads/Strategy_2007_2008_2012_2013.pdf [Accessed 2010 Nov 4]
27. The World Health Report 2000. Health Systems: Improving Performance. WHO Geneva, 2000 Available from URL: http://www.who.int/whr/2000/en/whr00_en.pdf [Accessed 2010 Nov 10]
28. Travis P, Egger D, Davies P, Mechbal A. Towards better stewardship: concepts and critical issues. Global Programme on Evidence for Health Policy Discussion Papers, No. 48. WHO Geneva, 2002. Available from URL: http://www.who.int/healthinfo/paper48.pdf [Accessed 2010 Nov 10]
29. Corruption widespread in Afghanistan, UNODC survey says. United Nations Office on Drugs and Crime. 19 Jan 2010. Available from URL: http://www.unodc.org/unodc/en/frontpage/2010/January/corruption-widespread-in-afghanistan-unodc-survey-says.html [Accessed 2010 Nov 10]
30. Hansen PM, Peters DH, Niayesh H, Singh LP, Dwivedi V, Burnham G. Measuring and managing progress in the establishment of basic health services: the Afghanistan health sector balanced scorecard. Int J Health Plann Manage. 2008 Apr-Jun; 23(2):107-17.
31. Babar ZU, Scahill SL. Evidence based pharmaceutical policy research: Is it all talk or does it contribute to improving health in developing countries? Southern Med Review (2010) 3; 1:1-1.
32. National Licensed Drugs List (December 2007). General Directorate of Pharmaceutical Affairs, Ministry of Public Health, Islamic Republic of Afghanistan; Essential Drug Department, Avicenna Pharmaceutical Institute. Available from URL: http://www.moph.gov.af/en/downloads/Afghanistan-National-Licensed-Drug-List-December-2007.pdf [accessed 2010 Nov 9]
33. Procedure for application for inclusion of medicines on the licensed drugs list of the Ministry of Public Health of Afghanistan (2007). General Directorate of Pharmaceutical Affairs, Ministry of Public Health, Islamic Republic of Afghanistan; Essential Drug Department, Avicenna Pharmaceutical Institute. Available from URL: http://www.moph.gov.af/en/downloads/Procedure-for-inclusion-of-medicine-in-LDL.pdf [accessed 2010 Nov 9]
34. Procedure for application for inclusion of medicines on the licensed drugs list of the Ministry of Public Health of Afghanistan 2006 Afghanistan Health Survey (AHS). Ministry of Public Health, Islamic Republic of Afghanistan. 2006. Available from URL: http://www.humanitarianreform.org/humanitarianreform/Portals/1/cluster%20approach%20page/Afghanistan/Afghanistan%20Health%20Survey%20Report%202006.pdf [Accessed 2010 Nov 10]
35. Procedure for application for inclusion of medicines on the essential drugs list of the Ministry of Public Health of Afghanistan (2007). General Directorate of Pharmaceutical Affairs, Ministry of Public Health, Islamic Republic of Afghanistan; Essential Drug Department, Avicenna Pharmaceutical Institute. Available from URL: http://www.moph.gov.af/en/downloads/Procedure-for-inclusion-medicine-in-EDL.pdf [accessed 2010 Nov 9]
36. Babar ZU, Scahill SL. Is There a Role for Pharmacoeconomics in Developing Countries? Pharmacoeconomics. 2010: 1-6
37. Afghanistan Statistical Yearbook 2009/2010. Central Statistics Organization (CSO), Islamic Republic of Afghanistan Available from URL: http://www.cso.gov.af/yearbook.zip [accessed 2011 Feb 17]